Guidelines & Consensus
Geriatric Assessment-Guided Care for Older Adults with Cancer: A Clinical Practice Review
Rizka et alActa Medica Indonesiana

Chronological age alone fails to capture physiological reserve, comorbidity, frailty, and functional status, which dictate how older patients tolerate antineoplastic treatment. Comprehensive geriatric assessment (CGA)—which systematically evaluates functional status, comorbidities, fall history, cognition, mood, nutritional state, polypharmacy, and social support—outperforms standard oncologic performance status in predicting severe chemotherapy toxicity, therapy completion, functional decline, and mortality.
Evidence from randomized clinical trials confirms that geriatric assessment-guided management significantly decreases severe chemotherapy toxicity and improves patient-provider communication regarding aging-related concerns, achieving these benefits without compromising patient survival.
To overcome practical clinic constraints, validated screening instruments such as the Geriatric-8 (G8) triage patients who warrant full CGA, while predictive calculators, including the Cancer and Aging Research Group (CARG) and Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) scores, refine individualized toxicity risk estimation to support shared treatment decisions. Although implementation faces barriers in resource-constrained environments due to limited geriatrician availability, time limitations, and reimbursement gaps, pragmatic models such as nurse-led or self-administered evaluations and stepwise pathways facilitate embedding geriatric assessment into standard multidisciplinary oncology care.
Key Takeaways
- Geriatric assessment-guided management reduces severe chemotherapy toxicity and enhances communication regarding aging-related concerns without compromising overall survival.
- Comprehensive geriatric assessment outperforms performance status alone in predicting chemotherapy-related toxicity, treatment completion, functional decline, and mortality in older adults with cancer.
- Screening with the Geriatric-8 identifies patients who require full evaluation, while the CARG and CRASH predictive scores risk-stratify patients for chemotherapy toxicity to facilitate shared clinical decision-making.
Read the original sourceActa Medica Indonesiana
